Workflow
Enfusion(ENFN)
icon
Search documents
Enfusion Announces Date of Fourth Quarter and Full Year 2023 Results
Businesswire· 2024-02-13 13:30
NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced it will release its fourth quarter and full year 2023 financial results before the U.S. financial markets open on Tuesday, March 12, 2024. Management will host a conference call and webcast that same morning at 5:30 AM (PT) / 8:30 AM (ET) to discuss the results. To access this call, dial (888) 596-4144. The conference ...
Enfusion to Host Investor Day on March 19, 2024
Businesswire· 2024-02-12 13:30
NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, will host an investor day in Fort Lauderdale, Florida on March 19th, 2024. The event will feature presentations from Enfusion’s executive team and provide an overview of Enfusion’s fully integrated investment technology platform, current and future market positioning, and growth outlook over the medium term. The formal presentations ...
Kore.ai Secures $150 Million Strategic Growth Investment to Drive AI-powered Customer and Employee Experiences for Global Brands
Prnewswire· 2024-01-30 12:00
Led by FTV Capital, with participation from NVIDIA and existing investors, funding will further solidify Kore.ai's leading position in explosive advanced AI market ORLANDO, Fla., Jan. 30, 2024 /PRNewswire/ -- Kore.ai, a leader in enterprise conversational and generative AI platform technology, today announced $150 million in funding. The strategic growth investment was led by FTV Capital, a sector-focused growth equity investor with a successful 25+ year track record investing across enterprise technology, ...
Enfusion(ENFN) - 2023 Q3 - Quarterly Report
2023-11-06 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40949 Enfusion, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other juri ...
Enfusion(ENFN) - 2023 Q2 - Earnings Call Transcript
2023-08-12 18:02
Enfusion, Inc. (NYSE:ENFN) Q2 2023 Results Conference Call August 8, 2023 8:30 AM ET Company Participants Iggy Njoku - Head, IR Oleg Movchan - CEO Brad Herring - CFO Conference Call Participants Kevin McVeigh - Credit Suisse Parker Lane - Stifel James Faucette - Morgan Stanley Callie Valenti - Goldman Sachs Dylan Becker - William Blair Operator Good morning, ladies and gentlemen, and thank you for standing by. Welcome to Enfusion Second Quarter 2023 Earnings Conference Call. [Operator Instructions] As a rem ...
Enfusion(ENFN) - 2023 Q2 - Quarterly Report
2023-08-07 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40949 Enfusion, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdict ...
Enfusion(ENFN) - 2023 Q1 - Earnings Call Transcript
2023-05-13 07:31
Financial Performance Highlights - Revenue grew 20% year-over-year to $41 million, reflecting resilient client demand for software and services [7][21] - Adjusted EBITDA was $5.7 million, representing a margin of 13.9%, up over 850 basis points from the same period last year [79] - Annual Recurring Revenue (ARR) increased 21% year-over-year to $167 million [7][80] - Adjusted gross profit increased by 19% year-over-year to $27.9 million, with an adjusted gross margin of 68.2% [22] Business Line Performance - In the EMEA region, revenue grew 37% year-over-year, driven by strong sales execution, particularly in the Middle East [10] - U.S. revenue grew 16% year-over-year, reflecting market dynamics and successful partnerships with large hedge funds [36] - APAC revenue increased by 20% year-over-year, with significant wins in the region, including a large long/short equity hedge fund in Singapore [40] Market Dynamics - The investment management space is facing sustained macroeconomic headwinds, but signs of stabilization are emerging [16] - The industry is undergoing digital transformation, moving from legacy systems to integrated solutions, which presents opportunities for growth [17] - There is a healthy pipeline for conversions and upmarket opportunities, driven by the need for cost optimization among fund managers [45] Company Strategy and Competitive Positioning - The company is focused on enhancing its competitive advantage through best-in-class software and services [4] - Strategic partnerships, such as with Qontigo, are aimed at broadening the partner ecosystem and enhancing client offerings [13][14] - The company is investing in its core platform to improve functionality and streamline client onboarding and support [19] Management Commentary on Future Outlook - Management remains optimistic about the second half of the year, expecting improved market dynamics as macro uncertainty decreases [16][52] - The company is reaffirming its full-year revenue guidance of $185 million to $190 million and adjusted EBITDA guidance of $32 million to $34 million [52] - Management acknowledges short-term volatility in net dollar retention but anticipates recovery as new clients are onboarded [49][106] Other Important Information - The company ended the quarter with approximately $55 million in cash and cash equivalents and no debt, providing flexibility for strategic initiatives [23] - The average size of customers has increased by approximately 10% compared to the same period last year, reflecting a strategy to move upmarket [81] Q&A Session Summary Question: What is the outlook for ARR growth for the rest of the year? - Management expects ARR to continue growing, with some short-term pressure on existing clients but acceleration anticipated as new clients are onboarded [100][101] Question: Are there any assumptions of an improving macro environment in the guidance? - The guidance reflects expectations of a slower first half but reaffirmation of anticipated improvements in the back half of the year [102][103] Question: How is the company addressing pricing dynamics in the current environment? - The company is not seeing general price compression and maintains a competitive edge through its comprehensive solutions [95][116] Question: Can you provide insights on client churn and its impact on NDR? - Voluntary churn remains low, with the majority of churn being involuntary due to market conditions; management is closely monitoring these trends [70][71] Question: What is the visibility on recent conversion wins and their impact on revenue? - Management sees visibility in hedge fund launches picking up, with monetization timelines varying based on the complexity of the launches [66][68]
Enfusion(ENFN) - 2023 Q1 - Quarterly Report
2023-05-08 16:00
Revenue Performance - Total revenues for the three months ended March 31, 2023, were $41.0 million, an increase of $6.8 million or 20.0% compared to $34.1 million for the same period in 2022[116] - Platform subscriptions revenue increased by $6.4 million or 20.4%, from $31.6 million in Q1 2022 to $38.0 million in Q1 2023, driven by new client revenues of $4.5 million[118] - Managed services revenue rose by $514 thousand or 23.0%, from $2.2 million in Q1 2022 to $2.7 million in Q1 2023, primarily due to upsells and new client revenues[119] - Approximately 99.4% of total revenues for Q1 2023 were recurring subscription-based, consistent with 98.9% in Q1 2022[94] Profitability - Gross profit increased by $4.5 million, from $23.2 million in Q1 2022 to $27.7 million in Q1 2023, with a gross profit margin of 67.5%[123] - Net income for the three months ended March 31, 2023, was $4.7 million, compared to a net loss of $12.5 million for the same period in 2022[96] Expenses - Total cost of revenues increased by $2.3 million or 21.1%, from $10.98 million in Q1 2022 to $13.3 million in Q1 2023, mainly due to increased payroll and hosting costs[122] - General and administrative expenses decreased by $7.8 million or 35.1%, from $22.3 million in Q1 2022 to $14.5 million in Q1 2023[124] - Sales and marketing expenses decreased by $4.3 million or 51.5%, from $8.4 million in Q1 2022 to $4.1 million in Q1 2023[124] - General and administrative expenses decreased by $7.8 million, from $22.3 million in Q1 2022 to $14.5 million in Q1 2023, primarily due to a $9.2 million decrease in stock-based compensation[125] - Sales and marketing expenses decreased by $4.3 million, from $8.4 million in Q1 2022 to $4.1 million in Q1 2023, mainly due to a $3.6 million decrease in stock-based compensation[126] - Technology and development expenses decreased by $371 thousand, from $4.8 million in Q1 2022 to $4.4 million in Q1 2023, primarily due to a $1.0 million decrease in stock-based compensation[127] Cash Flow and Liquidity - Net cash provided by operating activities was $924 thousand in Q1 2023, a $5.0 million increase compared to a cash used of $4.1 million in Q1 2022[136] - Net cash used in investing activities decreased by $621 thousand, from $3.2 million in Q1 2022 to $2.6 million in Q1 2023[139] - Cash flows from financing activities resulted in a cash outflow of $6.4 million in Q1 2023, compared to $805 thousand in Q1 2022, marking a significant increase of 689.2%[140] - As of March 31, 2023, the company had cash and cash equivalents of $54.6 million and $5 million in available borrowing capacity under its Revolving Debt[130] Future Outlook - The company continues to invest in research and development to enhance system functionality and open new revenue opportunities[95] - The company expects to issue approximately 15.8 million shares of Class A common stock between March 31, 2023, and October 20, 2023, which may impact liquidity and capital resources[133] - The company does not anticipate declaring or paying any cash dividends in the foreseeable future, intending to retain all available funds and future earnings[146] - The estimated amount of existing tax basis and basis adjustments acquired in the IPO is approximately $229.3 million, which may result in substantial payments under the Tax Receivable Agreement[147]
Enfusion(ENFN) - 2022 Q4 - Annual Report
2023-03-09 16:00
Revenue Growth and Market Expansion - Total revenues increased from $59.0 million in 2019 to $150.3 million in 2022, indicating significant growth[88]. - The company aims to penetrate markets outside the United States and expand into new client segments to drive revenue growth[84]. - International revenues represented approximately 38%, 34%, and 32% of total revenues for the fiscal years ended December 31, 2022, 2021, and 2020, respectively, highlighting the company's international market presence[130]. - No client represented more than 4% of total revenues during the year ended December 31, 2022, with the top 10 clients accounting for approximately 15% of total revenues, demonstrating revenue diversification[126]. Challenges and Risks - The company may face challenges in maintaining its revenue growth rate due to factors such as increasing competition and client retention issues[88]. - The adoption of cloud-based financial solutions is still at an early stage, and any slowdown in this trend could adversely affect sales[87]. - Fluctuations in quarterly operating results may occur due to various factors, making future performance difficult to predict[91]. - Economic and market conditions, including interest rate changes and reduced corporate profitability, may negatively impact clients' willingness to purchase the company's solutions[107]. - The competitive landscape is intensifying, with competitors having greater resources and potentially leading to pricing pressure and loss of market share[108][111]. - The company faces significant risks related to unauthorized access to client data, which could adversely impact its reputation and operations[98]. - Cyberattacks are increasing in frequency and sophistication, posing a threat to the company's systems and client data, potentially leading to operational disruptions and financial losses[99]. - The company faces significant risks related to software defects, which could lead to increased costs, loss of clients, and damage to reputation[120]. Operational and Resource Management - The company has expanded operations rapidly, which may strain operational and financial resources, impacting service levels[89]. - The company must effectively manage its growth and hiring needs to avoid negatively impacting its business strategy and service quality[90]. - The company must enhance its operational capabilities to manage a geographically dispersed workforce and client base effectively[119]. - High-quality technical support is critical for client retention and satisfaction, and failure to provide this could adversely affect revenues and profitability[138]. - The company faces significant competition for qualified personnel, particularly in cloud-based software development, which may impede growth if not addressed[143]. Financial and Compliance Considerations - The company’s revenue recognition practices may create volatility in financial results, making them difficult to predict due to factors like contract renewals and sales timing[177]. - The company is subject to restrictive covenants under its credit facility, which could impact operational flexibility and financial performance[193]. - Changes in tax laws, such as potential increases in the corporate tax rate, could negatively impact the company's effective tax rate and financial position[190]. - The company may incur substantial expenses to comply with evolving data protection regulations, which could adversely affect its results from operations[230]. Intellectual Property and Legal Risks - The company relies on a combination of confidentiality obligations, copyrights, trademarks, and trade secret laws to protect its intellectual property[196]. - Litigation may be necessary to enforce intellectual property rights, which could be costly and time-consuming, potentially impairing the company's operations[198]. - Claims of infringement by third parties could result in significant costs and harm the company's business operations[202]. - The company may need to license additional intellectual property from third parties to develop and market new systems, which may not be available on commercially reasonable terms[198]. Stock and Shareholder Considerations - As of December 31, 2022, the company is obligated to issue 17,225,377 shares of Class A common stock, which would increase the total outstanding shares by approximately 15.1%[185]. - The company may issue additional shares of Class A common stock, which could dilute existing stockholders' ownership[248]. - As of December 31, 2022, insiders owned approximately 73.1% of the combined voting power of the common stock, which may limit the influence of other stockholders on key transactions[249]. - Future offerings of debt or equity securities may adversely affect the market price of the company's Class A common stock[246]. Regulatory Environment and Compliance - The regulatory environment is continually changing, which could impose additional costs and affect the company's ability to support clients[210]. - The company is subject to the FCPA and similar anti-bribery laws, which could result in penalties if not complied with[217]. - Evolving data privacy and security regulations may impose additional costs and liabilities on the company, adversely affecting its business[219]. - The California Consumer Privacy Act (CCPA) and California Privacy Rights Act (CPRA) may increase compliance costs and potential liabilities for the company[225].
Enfusion(ENFN) - 2022 Q4 - Earnings Call Transcript
2023-03-07 18:17
Enfusion, Inc. (NYSE:ENFN) Q4 2022 Results Conference Call March 7, 2023 8:30 AM ET Company Participants Ignatius Njoku - Head, IR Oleg Movchan - CEO Brad Herring - CFO Conference Call Participants James Faucette - Morgan Stanley Kevin McVeigh - Credit Suisse Dylan Becker - William Blair Koji Ikeda - Bank of America Matthew Kikkert - Stifel Operator Good morning, ladies and gentlemen and thank you for standing by. Welcome to Enfusion's Fourth Quarter 2022 Earnings Conference Call. [Operator Instructions] A ...